326 related articles for article (PubMed ID: 33635573)
21. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
[TBL] [Abstract][Full Text] [Related]
23. Is it Possible to Implant HeartMate 3 Less Invasively? New Pump, New Approach.
Kocabeyoglu SS; Kervan U; Sert DE; Unal EU; Demirkan B; Guray Y; Aygun E; Beyazal OF; Karahan M; Pac M
Artif Organs; 2018 Dec; 42(12):1132-1138. PubMed ID: 30393885
[TBL] [Abstract][Full Text] [Related]
24. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
[TBL] [Abstract][Full Text] [Related]
25. A Tale of Two Centrifugal-Flow Ventricular Assist Devices As Bridge to Heart Transplant.
Alwair H; Whitehouse K; Slaughter MS; Trivedi JR
Ann Thorac Surg; 2022 Mar; 113(3):757-762. PubMed ID: 33857496
[TBL] [Abstract][Full Text] [Related]
26. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
[TBL] [Abstract][Full Text] [Related]
27. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
[TBL] [Abstract][Full Text] [Related]
28. The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure.
Vieira JL; Pfeffer M; Claggett BL; Stewart GC; Givertz MM; Coakley L; Mallidi HR; Mehra MR
J Heart Lung Transplant; 2020 Jun; 39(6):582-592. PubMed ID: 32220561
[TBL] [Abstract][Full Text] [Related]
29. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
Salerno CT; Hayward C; Hall S; Goldstein D; Saeed D; Schmitto J; Kaczorowski D; Molina E; Zimpfer D; Tsui S; Soltesz E; Pham DT; Mokadam NA; Kilic A; Davis E; Feller E; Lorts A; Silvestry S; Slaughter MS; Potapov E; Atluri P; Cowger J; Pagani FD;
J Thorac Cardiovasc Surg; 2022 Jun; 163(6):2120-2127.e5. PubMed ID: 35341579
[TBL] [Abstract][Full Text] [Related]
30. Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
Shehab S; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Robson D; Newton PJ; Rao S; Wang L; Allida S; Connellan M; Granger E; Dhital K; Spratt P; Jansz PC; Hayward CS
J Heart Lung Transplant; 2016 Apr; 35(4):466-73. PubMed ID: 26849954
[TBL] [Abstract][Full Text] [Related]
31. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.
Salerno CT; Hayward C; Hall S; Goldstein D; Saeed D; Schmitto J; Kaczorowski D; Molina E; Zimpfer D; Tsui S; Soltesz E; Pham DT; Mokadam NA; Kilic A; Davis E; Feller E; Lorts A; Silvestry S; Slaughter MS; Potapov E; Atluri P; Cowger J; Pagani FD;
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325091
[TBL] [Abstract][Full Text] [Related]
32. Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices.
Xanthopoulos A; Wolski K; Wang Q; Blackstone EH; Randhawa VK; Soltesz EG; Young JB; Nissen SE; Estep JD; Triposkiadis F; Starling RC
JACC Heart Fail; 2022 Feb; 10(2):89-100. PubMed ID: 35115092
[TBL] [Abstract][Full Text] [Related]
33. Survival and adverse events in patients with atrial fibrillation at left ventricular assist device implantation: an analysis of the European Registry for Patients with Mechanical Circulatory Support.
Antonides CFJ; Yalcin YC; Veen KM; Muslem R; De By TMMH; Bogers AJJC; Gustafsson F; Caliskan K
Eur J Cardiothorac Surg; 2022 May; 61(5):1164-1175. PubMed ID: 35076057
[TBL] [Abstract][Full Text] [Related]
34. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
[TBL] [Abstract][Full Text] [Related]
35. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
[TBL] [Abstract][Full Text] [Related]
36. An 18-month comparison of clinical outcomes between continuous-flow left ventricular assist devices.
Itzhaki Ben Zadok O; Ben-Avraham B; Shaul A; Hammer Y; Rubachevski V; Aravot D; Kornowski R; Ben-Gal T
Eur J Cardiothorac Surg; 2019 Dec; 56(6):1054-1061. PubMed ID: 31566245
[TBL] [Abstract][Full Text] [Related]
37. Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3-A EUROMACS Analysis.
Schweiger M; Hussein H; de By TMMH; Zimpfer D; Sliwka J; Davies B; Miera O; Meyns B
J Cardiovasc Dev Dis; 2023 Aug; 10(8):. PubMed ID: 37623364
[No Abstract] [Full Text] [Related]
38. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices.
Anjum A; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Civitello AB; Etheridge WB; Delgado RM; Simpson L; George JK; Nair AP; Frazier OH; Morgan JA
J Artif Organs; 2018 Sep; 21(3):285-292. PubMed ID: 29766321
[TBL] [Abstract][Full Text] [Related]
39. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.
Lalonde SD; Alba AC; Rigobon A; Ross HJ; Delgado DH; Billia F; McDonald M; Cusimano RJ; Yau TM; Rao V
J Card Surg; 2013 Sep; 28(5):604-10. PubMed ID: 23844652
[TBL] [Abstract][Full Text] [Related]
40. Short-term single-centre experience with the HeartMate 3 left ventricular assist device for advanced heart failure.
Nowacka A; Hullin R; Tozzi P; Barras N; Regamey J; Yerly P; Rosner L; Marcucci C; Rusca M; Liaudet L; Kirsch M
Eur J Cardiothorac Surg; 2020 Sep; 58(3):511-518. PubMed ID: 32236472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
